Molecular profiles as predictive marker for the effect of overall treatment time of radiotherapy in supraglottic larynx squamous cell carcinomas

This publication has 19 references indexed in Scilit:

• Molecular Marker Profiles Predict Locoregional Control of Head and Neck Squamous Cell Carcinoma in a Randomized Trial of Continuous Hyperfractionated Accelerated Radiotherapy
  Clinical Cancer Research, 2004
• Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression
  Cancer Cell, 2004
• Altered E-cadherin and epidermal growth factor receptor expressions are associated with patient survival in lung cancer: a study utilizing high-density tissue microarray and immunohistochemistry
  Laboratory Investigation, 2004
• Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of β-catenin, and enhanced tumor cell invasion
  Cancer Cell, 2003
• Acute and late normal tissue reactions in the DAHANCA 6&7 randomized trial with accelerated radiotherapy for head and neck cancer
  International Journal of Radiation Oncology*Biology*Physics, 2003
• Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial
  The Lancet, 2003
• Molecular markers in clinical radiation oncology
  Oncogene, 2003
• Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E-cadherin, epidermal growth factor receptor)
  Surgery Today, 1999
• Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation
  Oncogene, 1997
• Evidence that cadherins play a role in the downregulation of integrin expression that occurs during keratinocyte terminal differentiation
  The Journal of cell biology, 1994